Literature DB >> 8790604

Glucocerebrosidase mutations in Gaucher disease.

E Beutler1, A Demina, T Gelbart.   

Abstract

BACKGROUND: Thirty-six mutations that cause Gaucher disease, the most common glycolipid storage disorder, are known. Although both alleles of most patients with the disease contain one of these mutations, in a few patients one or both disease-producing alleles have remained unidentified. Identification of mutations in these patients is useful for genetic counseling.
MATERIALS AND METHODS: The DNA from 23 Gaucher disease patients in whom at least one glucocerebrosidase allele did not contain any of the 36 previously described mutations has been examined by single strand conformation polymorphism (SSCP) analysis, followed by sequencing of regions in which abnormalities were detected.
RESULTS: Eight previously undescribed mutations were detected. In exon 3, a deletion of a cytosine at cDNA nt 203 was found. In exon 6, three missense mutations were identified: a C-->A transversion at cDNA nt 644 (Ala176-->Asp), a C-->A transversion at cDNA nt 661 that resulted in a (Pro182-->Thr), and a G-->A transition at cDNA nt 721 (Gly202-->Arg). Two missense mutations were found in exon 7: a G-->A transition at cDNA nt 887 (Arg257-->Gln) and a C-->T at cDNA nt 970 (Arg285-->Cys). Two missense mutations were found in exon 9: a T-->G at cDNA nt 1249 (Trp378-->Gly) and a G-->A at cDNA nt 1255 (Asp380-->Asn). In addition to these disease-producing mutations, a silent C-->G transversion at cDNA nt 1431, occurring in a gene that already contained the 1226G mutation, was found in one family.
CONCLUSIONS: The mutations described here and previously known can be classified as mild, severe, or lethal, on the basis of their effect on enzyme production and on clinical phenotype, and as polymorphic or sporadic, on the basis of the haplotype in which they are found. Rare mutations such as the new ones described here are sporadic in nature.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8790604      PMCID: PMC2229932     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  29 in total

1.  Prevalent and rare mutations among Gaucher patients.

Authors:  N Eyal; S Wilder; M Horowitz
Journal:  Gene       Date:  1990-12-15       Impact factor: 3.688

2.  Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.

Authors:  S Tsuji; B M Martin; J A Barranger; B K Stubblefield; M E LaMarca; E I Ginns
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

3.  Characterization of mutations in Gaucher patients by cDNA cloning.

Authors:  M Wigderson; N Firon; Z Horowitz; S Wilder; Y Frishberg; O Reiner; M Horowitz
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

4.  The human glucocerebrosidase gene and pseudogene: structure and evolution.

Authors:  M Horowitz; S Wilder; Z Horowitz; O Reiner; T Gelbart; E Beutler
Journal:  Genomics       Date:  1989-01       Impact factor: 5.736

5.  Gaucher disease type 1: cloning and characterization of a cDNA encoding acid beta-glucosidase from an Ashkenazi Jewish patient.

Authors:  P N Graves; G A Grabowski; R Eisner; P Palese; F I Smith
Journal:  DNA       Date:  1988-10

6.  A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.

Authors:  S Tsuji; P V Choudary; B M Martin; B K Stubblefield; J A Mayor; J A Barranger; E I Ginns
Journal:  N Engl J Med       Date:  1987-03-05       Impact factor: 91.245

7.  Heterogeneity in type I Gaucher disease demonstrated by restriction mapping of the gene.

Authors:  J Sorge; T Gelbart; C West; B Westwood; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

8.  Gaucher disease associated with a unique KpnI restriction site: identification of the amino-acid substitution.

Authors:  E Beutler; T Gelbart
Journal:  Ann Hum Genet       Date:  1990-05       Impact factor: 1.670

9.  Sequence of two alleles responsible for Gaucher disease.

Authors:  C M Hong; T Ohashi; X J Yu; S Weiler; J A Barranger
Journal:  DNA Cell Biol       Date:  1990-05       Impact factor: 3.311

10.  Gaucher disease type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene.

Authors:  N Dahl; M Lagerström; A Erikson; U Pettersson
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

View more
  10 in total

1.  Neuronopathic and non-neuronopathic presentation of Gaucher disease in patients with the third most common mutation (D409H) in Spain.

Authors:  A Chabás; B Cormand; S Balcells; R González-Duarte; C Casanova; J Colomer; L Vilageliu; D Grinberg
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 2.  Inherited Arterial Calcification Syndromes: Etiologies and Treatment Concepts.

Authors:  Yvonne Nitschke; Frank Rutsch
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

3.  Type 2 Gaucher disease: the collodion baby phenotype revisited.

Authors:  D L Stone; W F Carey; J Christodoulou; D Sillence; P Nelson; M Callahan; N Tayebi; E Sidransky
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

4.  Recurrence of the D409H mutation in Spanish Gaucher disease patients: description of a new homozygous patient and haplotype analysis.

Authors:  A Chabás; L Gort; M Montfort; F Castelló; M C Domínguez; D Grinberg; L Vilageliu
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

5.  Identification and expression of acid beta-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients.

Authors:  M E Grace; R J Desnick; G M Pastores
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

6.  A novel genotype c.1228C>G/c.1448C-1498C (L371V/Rec-NciI) in a 3-year-old child with type 1 Gaucher disease.

Authors:  Nabil A Yassin; Samar A Muwakkit; Ahmad O Ibrahim; Imad M Kayim; Mohammad-Zohair M Habbal; Nabil M Chamseddine; Khaled M Musallam; Ali I Shamseddine
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

7.  Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies.

Authors:  Joshua T Geiger; Jinhui Ding; Barbara Crain; Olga Pletnikova; Christopher Letson; Ted M Dawson; Liana S Rosenthal; Alexander Pantelyat; J Raphael Gibbs; Marilyn S Albert; Dena G Hernandez; Argye E Hillis; David J Stone; Andrew B Singleton; John A Hardy; Juan C Troncoso; Sonja W Scholz
Journal:  Neurobiol Dis       Date:  2016-06-14       Impact factor: 5.996

Review 8.  The lysosomal function of progranulin, a guardian against neurodegeneration.

Authors:  Daniel H Paushter; Huan Du; Tuancheng Feng; Fenghua Hu
Journal:  Acta Neuropathol       Date:  2018-05-09       Impact factor: 17.088

9.  Genetic and clinical characteristics of Filipino patients with Gaucher disease.

Authors:  Mary Anne D Chiong; Marie Julianne C Racoma; Mary Ann R Abacan
Journal:  Mol Genet Metab Rep       Date:  2018-04-05

10.  A familial concurrence of schizophrenia and Gaucher's disease.

Authors:  Odysseas D Mouzas; Konstantinos E Siomos; Nikiforos V Angelopoulos
Journal:  Ann Gen Psychiatry       Date:  2007-12-17       Impact factor: 3.455

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.